Your browser doesn't support javascript.
loading
Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.
Grogan, Patrick T; Deming, Dustin A; Helgager, Jeffrey; Ruszkiewicz, Theresa; Baskaya, Mustafa K; Howard, Steven P; Robins, H Ian.
Afiliação
  • Grogan PT; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
  • Deming DA; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
  • Helgager J; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
  • Ruszkiewicz T; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA.
  • Baskaya MK; Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin, USA.
  • Howard SP; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA.
  • Robins HI; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
Neurooncol Adv ; 4(1): vdac046, 2022.
Article em En | MEDLINE | ID: mdl-35673607
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos